Quadrant Capital Group’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23
Closed -$17 2785
2024
Q1
$17 Hold
23
﹤0.01% 2715
2023
Q4
$41 Hold
23
﹤0.01% 2687
2023
Q3
$34 Hold
23
﹤0.01% 2682
2023
Q2
$60 Hold
23
﹤0.01% 2678
2023
Q1
$85 Hold
23
﹤0.01% 2707
2022
Q4
$41 Sell
23
-22
-49% -$59 ﹤0.01% 2725
2022
Q3
$0 Hold
45
﹤0.01% 2847
2022
Q2
$0 Hold
45
﹤0.01% 2802
2022
Q1
$1K Hold
45
﹤0.01% 2435
2021
Q4
$1K Buy
+45
New +$1.08K ﹤0.01% 2446

Other funds holding DMTK

Quadrant Capital Group's DMTK Position: Q2 2024 in Review

Quadrant Capital Group sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 23 shares — an estimated $17 sold.

Quadrant Capital Group first reported a position in DMTK in Q4 2021 and held it in 10 quarters. The position peaked at $1K in Q1 2022. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Quadrant Capital Group reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Quadrant Capital Group sold 23 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $17.
  • Quadrant Capital Group first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Quadrant Capital Group's DermTech, Inc. Common Stock position peaked at $1K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Quadrant Capital Group's 13F filing for Q2 2024, filed 12 Aug 2024.